<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39411489</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>16</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>18</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2296-2565</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in public health</Title><ISOAbbreviation>Front Public Health</ISOAbbreviation></Journal><ArticleTitle>Epidemiological overlaps in COVID-19 and malaria within healthcare and community settings of Southern Ghana.</ArticleTitle><Pagination><StartPage>1367586</StartPage><MedlinePgn>1367586</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1367586</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fpubh.2024.1367586</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">COVID-19 disruptions including lockdowns and prioritization of COVID-19 control programs in Africa in 2020-2022 contributed to reductions in malaria control activities including malaria diagnosis, treatment and resistance monitoring. This study investigated the malaria burden and distribution on the background of active transmission of SARS-CoV-2 in Southern Ghana; utilizing community health education and medical screening (CHEMS) approach to determine epidemiological overlaps in COVID-19 and malaria.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Between October-December 2022, prospective cross-sectional surveys, with CHEMS were conducted in Greater Accra and Central regions, where 994 participants enrolled either at a hospital or community setting provided demographic and clinical data including history of clinical malaria infection and antimalarial treatment in the past 2 weeks. Of this study population, 953 provided nasal/throat swabs for COVID-19 RT-PCR testing, with a subset of 136 participants also providing finger-prick blood for malaria RDT testing.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The study population comprised of 73.6% adults, with 54.6% COVID-19 vaccination rate. Overall, 18.1% of participants had a history of clinical malaria, which was associated (adjusted odds ratio &gt; 1.50, <i>p</i>-value ≤0.022) with COVID-19 symptoms and positivity, study area and hospital setting, suggestive of overlaps in the epidemiological risk for malaria. On a background of widespread SARS-CoV-2 infections (12-37%), malaria parasitaemia was detected in 6%, with 2% being co-infections with SARS-CoV-2. Among the malaria positives, 9.5% had a history of antimalarial treatment, which suggested that their infections were recrudescent parasitaemia.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">The epidemiological and clinical overlap between malaria and COVID-19 within the hospital and community settings underscores the need for accurate case diagnosis to inform effective clinical treatments. Innovative surveillance programs, with community engagement are needed to maximize control interventions including treatment of asymptomatic malaria infections.</AbstractText><CopyrightInformation>Copyright © 2024 Amegatcher, Acquah, Tetteh, Obeng, Debrah, Quist, Acquah-Jackson, Boateng, Twieku, Armoo, Awandare, Mosi and Narh.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Amegatcher</LastName><ForeName>Gloria</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>West African Centre for Cell Biology of Infectious Pathogens (WACBIP), Department of Biochemistry, Cell and Molecular Biology, University of Ghana, Accra, Ghana.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Laboratory Sciences, University of Ghana, Accra, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Acquah</LastName><ForeName>Maame E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>West African Centre for Cell Biology of Infectious Pathogens (WACBIP), Department of Biochemistry, Cell and Molecular Biology, University of Ghana, Accra, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tetteh</LastName><ForeName>Deborah K</ForeName><Initials>DK</Initials><AffiliationInfo><Affiliation>West African Centre for Cell Biology of Infectious Pathogens (WACBIP), Department of Biochemistry, Cell and Molecular Biology, University of Ghana, Accra, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Obeng</LastName><ForeName>Rachael</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>West African Centre for Cell Biology of Infectious Pathogens (WACBIP), Department of Biochemistry, Cell and Molecular Biology, University of Ghana, Accra, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Debrah</LastName><ForeName>Ethel</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>West African Centre for Cell Biology of Infectious Pathogens (WACBIP), Department of Biochemistry, Cell and Molecular Biology, University of Ghana, Accra, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quist</LastName><ForeName>Bridget</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>West African Centre for Cell Biology of Infectious Pathogens (WACBIP), Department of Biochemistry, Cell and Molecular Biology, University of Ghana, Accra, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Acquah-Jackson</LastName><ForeName>Priscilla</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>West African Centre for Cell Biology of Infectious Pathogens (WACBIP), Department of Biochemistry, Cell and Molecular Biology, University of Ghana, Accra, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boateng</LastName><ForeName>Kyerewaa A</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>West African Centre for Cell Biology of Infectious Pathogens (WACBIP), Department of Biochemistry, Cell and Molecular Biology, University of Ghana, Accra, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Twieku</LastName><ForeName>Gideon</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Biomedical and Public Health Research Unit, Council for Scientific and Industrial Research - Water Research Institute, Accra, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Armoo</LastName><ForeName>Samuel</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Biomedical and Public Health Research Unit, Council for Scientific and Industrial Research - Water Research Institute, Accra, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Awandare</LastName><ForeName>Gordon A</ForeName><Initials>GA</Initials><AffiliationInfo><Affiliation>West African Centre for Cell Biology of Infectious Pathogens (WACBIP), Department of Biochemistry, Cell and Molecular Biology, University of Ghana, Accra, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mosi</LastName><ForeName>Lydia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>West African Centre for Cell Biology of Infectious Pathogens (WACBIP), Department of Biochemistry, Cell and Molecular Biology, University of Ghana, Accra, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Narh</LastName><ForeName>Charles A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>West African Centre for Cell Biology of Infectious Pathogens (WACBIP), Department of Biochemistry, Cell and Molecular Biology, University of Ghana, Accra, Ghana.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Deakin University, Geelong, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, University of Melbourne, Parkville, VIC, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Public Health</MedlineTA><NlmUniqueID>101616579</NlmUniqueID><ISSNLinking>2296-2565</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000962">Antimalarials</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005869" MajorTopicYN="N" Type="Geographic">Ghana</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008288" MajorTopicYN="Y">Malaria</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000962" MajorTopicYN="N">Antimalarials</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Ghana</Keyword><Keyword MajorTopicYN="N">co-surveillance</Keyword><Keyword MajorTopicYN="N">community and healthcare</Keyword><Keyword MajorTopicYN="N">diagnostics</Keyword><Keyword MajorTopicYN="N">epidemiological overlap</Keyword><Keyword MajorTopicYN="N">malaria</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>10</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>4</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39411489</ArticleId><ArticleId IdType="pmc">PMC11473434</ArticleId><ArticleId IdType="doi">10.3389/fpubh.2024.1367586</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO . World malaria report 2022. Geneva, Switzerland: World Health Organization. (2022). p. 1–322.</Citation></Reference><Reference><Citation>Weiss DJ, Bertozzi-Villa A, Rumisha SF, Amratia P, Arambepola R, Battle KE, et al. . Indirect effects of the COVID-19 pandemic on malaria intervention coverage, morbidity, and mortality in Africa: a geospatial modelling analysis. Lancet Infect Dis. (2021) 21:59–69. doi: 10.1016/S1473-3099(20)30700-3, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30700-3</ArticleId><ArticleId IdType="pmc">PMC7505634</ArticleId><ArticleId IdType="pubmed">32971006</ArticleId></ArticleIdList></Reference><Reference><Citation>Dzianach PA, Rumisha SF, Lubinda J, Saddler A, van den Berg M, Gelaw YA, et al. . Evaluating COVID-19-related disruptions to effective malaria case management in 2020-2021 and its potential effects on malaria burden in sub-Saharan Africa. Trop Med Infect Dis. (2023) 8:4216. doi: 10.3390/tropicalmed8040216</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/tropicalmed8040216</ArticleId><ArticleId IdType="pmc">PMC10143572</ArticleId><ArticleId IdType="pubmed">37104342</ArticleId></ArticleIdList></Reference><Reference><Citation>Heuschen A-K, Abdul-Mumin A, Adokiya M, Lu G, Jahn A, Razum O, et al. . Impact of the COVID-19 pandemic on malaria cases in health facilities in northern Ghana: a retrospective analysis of routine surveillance data. Malar J. (2022) 21:149. doi: 10.1186/s12936-022-04154-1, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12936-022-04154-1</ArticleId><ArticleId IdType="pmc">PMC9107588</ArticleId><ArticleId IdType="pubmed">35570272</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng NI, Tabong PT, Netongo PM, Mensah BA, Chu CE, Yaw EB, et al. . The impact of COVID-19 on implementation of mass testing, treatment and tracking of malaria in rural communities in Ghana: a qualitative study. PLoS One. (2022) 17:e0275976. doi: 10.1371/journal.pone.0275976, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0275976</ArticleId><ArticleId IdType="pmc">PMC9560137</ArticleId><ArticleId IdType="pubmed">36227933</ArticleId></ArticleIdList></Reference><Reference><Citation>Adachi M, Taniguchi K, Hori H, Mizutani T, Ishizaka A, Ishikawa K, et al. . Strengthening surveillance in Ghana against public health emergencies of international concern. Trop Med Health. (2022) 50:81. doi: 10.1186/s41182-022-00473-w, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41182-022-00473-w</ArticleId><ArticleId IdType="pmc">PMC9617445</ArticleId><ArticleId IdType="pubmed">36307880</ArticleId></ArticleIdList></Reference><Reference><Citation>WACBIP . WACCBIP conducts free screening for COVID-19 exposure, gears up for serological study. (2022). Available at:
https://www.waccbip.org/news-events/news/waccbip-conducts-free-screening-for-covid-19-exposure-gears-up-for-serological-study (Accessed July 8, 2024).</Citation></Reference><Reference><Citation>Heuschen A-K, Abdul-Mumin A, Abubakari A, Agbozo F, Lu G, Jahn A, et al. . Effects of the COVID-19 pandemic on general health and malaria control in Ghana: a qualitative study with mothers and health care professionals. Malar J. (2023) 22:78. doi: 10.1186/s12936-023-04513-6, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12936-023-04513-6</ArticleId><ArticleId IdType="pmc">PMC9986038</ArticleId><ArticleId IdType="pubmed">36872343</ArticleId></ArticleIdList></Reference><Reference><Citation>Morang'a CM, Ngoi JM, Gyamfi J, Amuzu DSY, Nuertey BD, Soglo PM, et al. . Genetic diversity of SARS-CoV-2 infections in Ghana from 2020-2021. Nat Commun. (2022) 13:2494. doi: 10.1038/s41467-022-30219-5, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30219-5</ArticleId><ArticleId IdType="pmc">PMC9076825</ArticleId><ArticleId IdType="pubmed">35523782</ArticleId></ArticleIdList></Reference><Reference><Citation>Tapela K, Oyawoye FO, Olwal CO, Opurum PC, Amponsah JA, Segbedzi KAL, et al. . Probing SARS-CoV-2-positive plasma to identify potential factors correlating with mild COVID-19 in Ghana, West Africa. BMC Med. (2022) 20:370. doi: 10.1186/s12916-022-02571-2, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-022-02571-2</ArticleId><ArticleId IdType="pmc">PMC9527094</ArticleId><ArticleId IdType="pubmed">36184636</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan FHM, Ataide R, Richards JS, Narh CA. Contrasting epidemiology and population genetics of COVID-19 infections defined by multilocus genotypes in SARS-CoV-2 genomes sampled globally. Viruses. (2022) 14:1434. doi: 10.3390/v14071434, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14071434</ArticleId><ArticleId IdType="pmc">PMC9316073</ArticleId><ArticleId IdType="pubmed">35891414</ArticleId></ArticleIdList></Reference><Reference><Citation>McArthur L, Sakthivel D, Ataide R, Chan F, Richards JS, Narh CA. Review of burden, clinical definitions, and management of COVID-19 cases. Am J Trop Med Hygiene. (2020) 103:625–38. doi: 10.4269/ajtmh.20-0564, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.20-0564</ArticleId><ArticleId IdType="pmc">PMC7410412</ArticleId><ArticleId IdType="pubmed">32618260</ArticleId></ArticleIdList></Reference><Reference><Citation>NMEP . NATIONAL MALARIA ELIMINATION STRATEGIC PLAN (NMESP) OF GHANA: 2024–2028. Ghana: Ministry of Health, Ghana Health Services. (2023) Available at: https://ghs.gov.gh/wp-content/uploads/2023/12/NMEP-STRATEGIC%20PLAN%202024-2028.pdf (Accessed July 8, 2024).</Citation></Reference><Reference><Citation>Obboh EK, Okonu RE, Amoah LE. Large variations in malaria parasite carriage by afebrile school children living in nearby communities in the central region of Ghana. J Trop Med. (2020) 2020:4125109.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7528039</ArticleId><ArticleId IdType="pubmed">33029151</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiedje KE, Oduro AR, Bangre O, Amenga-Etego L, Dadzie SK, Appawu MA, et al. . Indoor residual spraying with a non-pyrethroid insecticide reduces the reservoir of plasmodium falciparum in a high-transmission area in northern Ghana. PLoS Global Public Health. (2022) 2:e0000285. doi: 10.1371/journal.pgph.0000285, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgph.0000285</ArticleId><ArticleId IdType="pmc">PMC9121889</ArticleId><ArticleId IdType="pubmed">35600674</ArticleId></ArticleIdList></Reference><Reference><Citation>Narh CA, Ghansah A, Duffy MF, Ruybal-Pesantez S, Onwona CO, Oduro AR, et al. . Evolution of antimalarial drug resistance markers in the reservoir of plasmodium falciparum infections in the upper east region of Ghana. J Infect Dis. (2020) 222:1692–701. doi: 10.1093/infdis/jiaa286, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiaa286</ArticleId><ArticleId IdType="pmc">PMC7982568</ArticleId><ArticleId IdType="pubmed">32459360</ArticleId></ArticleIdList></Reference><Reference><Citation>GHS . COVID-19; Ghana’s outbreak response management updates. (2023). Available at:
https://www.ghs.gov.gh/covid19/ (Accessed July 8, 2024).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>